Home
>
National Drug Code (NDC)
>
zaleplon
zaleplon - 63629-3405-2 - (zaleplon)
Drug Information of zaleplon
| Product NDC: | 63629-3405 |
| Proprietary Name: | zaleplon |
| Non Proprietary Name: | zaleplon |
| Active Ingredient(s): | 10 mg/1 & nbsp; zaleplon |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of zaleplon
| Product NDC: | 63629-3405 |
| Labeler Name: | Bryant Ranch Prepack |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078989 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090505 |
Package Information of zaleplon
| Package NDC: | 63629-3405-2 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (63629-3405-2) |
NDC Information of zaleplon
| NDC Code | 63629-3405-2 |
| Proprietary Name | zaleplon |
| Package Description | 30 CAPSULE in 1 BOTTLE (63629-3405-2) |
| Product NDC | 63629-3405 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zaleplon |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20090505 |
| Marketing Category Name | ANDA |
| Labeler Name | Bryant Ranch Prepack |
| Substance Name | ZALEPLON |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | gamma-Aminobutyric Acid A Receptor Agonist [EPC],GABA A Agonists [MoA],Central Nervous System Depression [PE] |
